One of the greatest sociological studies ever conducted is the Harvard Study of Adult Development. For 75 years, researchers tracked the lives of 724 men, of which 60 are still alive today. The detailed in-home research included two groups of…
FibroFluttersRather than technology taking the place of human interaction, digital health assistants should open the door for human interactions to be more valuable and enjoyable.
By Herman F. Bozenhardt and Erich H. Bozenhardt In our many years in the pharmaceutical business we have witnessed the introduction of revolutionary therapeutic products and designed and built plants with the latest process technology and in doing…
FibroFluttersAfter that statement sunk in, they were asked why there were splatters of white API over certain vessel domes and piping sections. They were then informed that the splatters were not API; they were pigeon droppings!
November is Pancreatic Cancer Awareness Month. Pancreatic cancer is the third leading cause of cancer-related deaths in the United States — surpassing breast cancer — and is expected to surpass colon cancer deaths in 2020. Cancer…
An estimated 56,770 people in the U.S. will be diagnosed with pancreatic cancer this year — more than 150 per day face this devastating diagnosis.
Last week, Derek A. Haas, Chief Executive Officer of healthcare technology and analytics company – Avant-garde Health; Eric C. Makhni, Sports Medicine Orthopedic Surgeon at Henry Ford Health System; Joseph H. Schwab, Associate Professor of…
FibroFluttersML is not about replacing the physicians
Seventeen years into the game, Alnylam's pivot into commercial operations is picking up speed. The bellwether biotech $ALNY has nabbed their second FDA OK, this time for givosiran, the only drug now approved for acute hepatic porphyria. This second…
FibroFluttersThe bellwether biotech $ALNY has nabbed their second FDA OK for an RNAi drug, this time for givosiran, the only therapy now approved for acute hepatic porphyria.
MEP Interest Group on Antimicrobial Resistance The AMR MEP Interest Group is the only dedicated group of MEPs working together to take action to combat one of the greatest global health threats of our time. Participating MEPs are concerned by the…
FibroFluttersParticipating MEPs are concerned by the rise in drug-resistant infections and believe that European cooperation is vital. No single country can tackle this cross-border threat alone.
Science X staff
– Nov 20, 2019, 1:00 PM
People with tremors in their hands, head or voice may find some relief for up to three years from a treatment using ultrasound waves to destroy the area of the brain causing the tremor, according to a study published in the November 20, 2019…
FibroFluttersEssential tremor is the most common type of tremor disorder. It can be disabling for the over 7 million people in the United States living with the disorder. The condition may cause problems with daily activities such as eating, writing or shaving.
Science X staff
– Nov 20, 2019, 7:00 AM
Researchers at the Children's Hospital Colorado Breathing Institute, one of the largest cystic fibrosis (CF) clinical care centers in the U.S., are part of a Therapeutics Development Network that oversaw clinical trials leading to FDA approval of…
FibroFluttersEventually researchers hope the treatment will be approved for use beginning in early infancy, which could prevent the devastating lung damage and disease progression that commonly occurs in CF.TRIKAFTA will help approximately 90% of people living with CF
Science X staff
– Nov 20, 2019, 8:25 AM
A new suicide prevention programme which includes swift access to specialist care and 12 months of telephone follow-ups has shown to reduce deaths by 17 per cent. The programme, called Suicide Prevention by Monitoring and Collaborative Care…
FibroFluttersThe study was led by researchers at the University of York in a joint collaboration with Tilburg University, the Netherlands. The network of partners based in the Noord-Brabant region of the Netherlands concentrated on four elements
– Nov 20, 2019, 4:57 AM
I'm a geneticist. I study the connection between information and biology—essentially what makes a fly a fly and a human a human. Interestingly, we're not that different. I've been a professional geneticist since the early 1990s. I'm…
FibroFluttersWe can't know when we're wrong, but it's important to remain open-minded and adaptable so we can learn from our mistakes. Especially because sometimes the stakes can be incredibly high with lives on the line